Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05752149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial

Study acronym: STELLAR
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Feb 1, 2027 → Mar 31, 2028
See other at-risk trials from Erasmus Medical Center

Record History

  1. Primary completion pushed from Feb 1, 2027 to Mar 31, 2028 Recruitment opened · Start date changed from estimate of Jun 1, 2025 to Mar 31, 2026 · Completion pushed from Mar 1, 2027 to Mar 31, 2028 · 1 morev6 Show 4 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Jun 1, 2025 to Mar 31, 2026
    • Completion pushed from Mar 1, 2027 to Mar 31, 2028
    • Study sites: 1 to 2
  2. Primary completion date: May 2025 to Feb 1, 2027 Start date: Sep 2024 to Jun 1, 2025 · Completion date: Nov 2025 to Mar 1, 2027v5 Show 2 more changesShow less
    • Start date: Sep 2024 to Jun 1, 2025
    • Completion date: Nov 2025 to Mar 1, 2027
  3. Start date: Jun 2024 to Sep 2024v4
  4. Start date: May 2023 to Jun 2024 Primary completion date: Nov 2024 to May 2025 · Completion date: May 2025 to Nov 2025v3 Show 2 more changesShow less
    • Primary completion date: Nov 2024 to May 2025
    • Completion date: May 2025 to Nov 2025
  5. Study title revisedv2 See this version in full on ClinicalTrials.gov ↗
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open-label, single-dose, prospective clinical trial. The study comprises 2 work packages. The main objective of work package I (WP-1) is to assess feasibility of Fluorescence imaing (FLI) during total laryngectomy (TLE) and to assess the optimal dose of the cRGD-ZW800-1. Work package II (WP-II) is designed to assess whether FLI can detect and decrease tumor positive margins after a TLE.
Trial Details
NCT Number NCT05752149
Lead Sponsor Erasmus Medical Center
Conditions Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx
Enrollment 27 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov